HST Global, Inc. (OTCPK: HSTC)
Health Care · Biotechnology · US
$0.10
-85.71% today · +890.1% 1Y
HST Global, Inc. (OTCPK: HSTC) operates in the Biotechnology industry within the Health Care sector. The company is valued at $14.14M and employs 1 people.
Over the last twelve months the share price has gained 890.1%, trading between 0.01 and 1.05.
Tweenvest scores HST Global, Inc. across four factors: quality 68/100, value 40/100. Its strongest factor is quality.
HSTC price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $14.14M
- Revenue (TTM)
- —
- P/E
- —
- EPS
- -0.00
- Dividend yield
- —
- Beta (5Y)
- -388.96
- 52-week high
- $1.05
- 52-week low
- $0.01
- Avg volume (3M)
- —
- Shares outstanding
- 141.43M
- Employees
- 1
- Next earnings
- —
About HST Global, Inc.
HST Global, Inc. operates in the healthcare, software and media, and transportation industries. It offers Qwyit, a cryptographic protocol. HST Global, Inc. is based in Virginia Beach, Virginia.
- ISIN
- US40432E2028
- Listed since
- Jun 24, 2002
- Exchange
- Pink Sheets LLC
- Currency
- USD
Other Biotechnology companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Xintela AB (publ)OM: XINT | $14.98M | Skr0.17 | -4.87% |
| Aptamer Group PLCAIM: APTA | $14.86M | £0.00 | +1.54% |
| SenzaGen ABOM: SENZA | $14.67M | Skr4.50 | -0.66% |
| Karyopharm Therapeutics Inc.NasdaqGS: KPTI | $14.63M | $0.65 | -0.75% |
| Abera Bioscience ABNGM: ABERA | $14.09M | Skr6.86 | +2.39% |
| AEON Biopharma, Inc.NYSEAM: AEON | $13.92M | $0.31 | +11.54% |
| Initiator Pharma A/SOM: INIT | $13.85M | Skr1.72 | -15.27% |
| IN8bio, Inc.NasdaqCM: INAB | $13.80M | $1.40 | 0.00% |
Figures last refreshed Oct 4, 2026.